诺辉健康(06606.HK) 公布，近期推出了三款产品，即常卫清，为一种专有非侵入性粪便FIT-DNA结直肠癌筛查测试产品；噗噗管，一种专有非侵入性粪便FIT筛查产品，用来测试与结直肠癌相关的血红蛋白生物标志物；及幽幽管，一种基于粪便样本幽门螺杆菌的筛查消费者自测产品。产品已根据医疗仪器行政管理制度(MDACS)于香港卫生署成功登记。
MDACS为医疗仪器登记制度，据此，医疗仪器制造商及进口商在证明有关医疗仪器符合公认的安全及性能标准后，可自愿向卫生署登记其医疗仪器。
公司股份已自3月28日起于联交所暂停买卖，并将继续暂停买卖直至履行复牌指引。(sl/u)(港股报价延迟最少十五分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.